Literature DB >> 33521133

Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome.

Rui Han1,2,3, Xiaoyun Gong4, Yuejie Zhu4, Xiaoran Liu1, Yan Xia1, Yuhong Huang2, Meng Zhang4, Yunian Zhang2, Xiaolin La4, Jianbing Ding2,3.   

Abstract

This study is to investigate the relationship of programmed cell death 1 (PD-1; also known as PDCD1) and programmed death-1-ligand 1 (PD-L1; also known as CD274) single nucleotide polymorphisms (SNPs) with polycystic ovary syndrome (PCOS). This study enrolled 330 PCOS patients and 350 matched controls. ELISA was used to detect the PD-1 and PD-L1 levels in serum. SnaPshot genotyping was performed to analyze the PD-1 and PD-L1 genotyping. Linkage disequilibrium and haplotype of TagSNP loci of PD-1 and PD-L1 genes were also detected. The relationship of genotypes and alleles with PCOS was analyzed. The levels of PD-1 and PD-L1 in the serum of PCOS patients were significantly lower than those in the control group (P < 0.01). The haplotype TT of PD-1 gene at rs10204525 and rs7421861 loci was significantly lower in the PCOS group than in the control group (P < 0.001, OR = 0.67, and 95%CI = 0.54-0.84). PD-L1 gene SNP loci rs2282055, rs2890658, rs10125854, and rs702275 had linkage disequilibrium. The haplotypes TAAA, GAAC, GAGC, GCAA, and TCGA of PD-L1 gene SNP loci were significantly higher in PCOS patients than in the control group, whereas haplotypes GAAA, TAAC, TCAA, GCGA, GCAC, and TCGC of PD-L1 gene SNP loci were significantly lower in PCOS patients than in the control group. PD-1 and PD-L1 SNPs may be related to the pathogenesis of PCOS. PD-1 gene SNP loci rs10204525 and rs7421861 and PD-L1 gene SNP loci rs2282055, rs2890658, rs10125854, and rs702275 may be new candidate polymorphic loci for PCOS.
Copyright © 2021 Rui Han et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33521133      PMCID: PMC7817229          DOI: 10.1155/2021/9596358

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  35 in total

1.  Rapid rare ABO blood typing using a single PCR based on a multiplex SNaPshot reaction.

Authors:  Ding-Ping Chen; Ying-Hao Wen; Jang-Jih Lu; Ching-Ping Tseng; Wei-Ting Wang
Journal:  J Formos Med Assoc       Date:  2018-06-30       Impact factor: 3.282

2.  Polycystic ovary syndrome, personality, and depression: A twin study.

Authors:  Carolyn E Cesta; Ralf Kuja-Halkola; Kelli Lehto; Anastasia N Iliadou; Mikael Landén
Journal:  Psychoneuroendocrinology       Date:  2017-08-10       Impact factor: 4.905

3.  Methylene tetrahydrofolate reductase and methionine synthase gene polymorphisms as genetic determinants of pre-eclampsia.

Authors:  V O Osunkalu; I A Taiwo; C C Makwe; R A Quao
Journal:  Pregnancy Hypertens       Date:  2020-02-10       Impact factor: 2.899

Review 4.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

5.  Association of programmed death-1 gene polymorphism rs2227981 with tumor: evidence from a meta analysis.

Authors:  Umarjan Mamat; Muyassar Arkinjan
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population.

Authors:  Kek Heng Chua; Lay Hoong Lian; Xiu Jia Sim; Tien Eang Cheah; Tze Pheng Lau
Journal:  Int J Mol Sci       Date:  2015-04-29       Impact factor: 5.923

7.  Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.

Authors:  Takashi Nomizo; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Yuto Yasuda; Hironori Yoshida; Yoshitaka Yagi; Yuichi Sakamori; Hiroki Nagai; Toyohiro Hirai; Young Hak Kim
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

8.  Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies.

Authors:  Mohammad Hashemi; Shima Karami; Sahel Sarabandi; Abdolkarim Moazeni-Roodi; Andrzej Małecki; Saeid Ghavami; Emilia Wiechec
Journal:  Cancers (Basel)       Date:  2019-08-10       Impact factor: 6.639

9.  Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with gastric cancer.

Authors:  Sanaz Savabkar; Pedram Azimzadeh; Vahid Chaleshi; Ehsan Nazemalhosseini Mojarad; Hamid Asadzadeh Aghdaei
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

10.  Variant SNPs at the microRNA complementary site in the B7‑H1 3'‑untranslated region increase the risk of non‑small cell lung cancer.

Authors:  Wenwen Du; Jianjie Zhu; Yanbin Chen; Yuanyuan Zeng; Dan Shen; Nan Zhang; Weiwei Ning; Zeyi Liu; Jian-An Huang
Journal:  Mol Med Rep       Date:  2017-06-30       Impact factor: 2.952

View more
  2 in total

1.  Sodium-glucose cotransporter-2 inhibitors for improving endocrine and metabolic profiles in overweight and obese individuals with polycystic ovary syndrome: a meta-analysis protocol.

Authors:  Jiaqi Zhang; Chuan Xing; Bing He
Journal:  BMJ Open       Date:  2022-04-25       Impact factor: 3.006

Review 2.  Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome.

Authors:  Ahmad J H Albaghdadi; Frederick W K Kan
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.